Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to 0.8.

  • Medifast's Equity Ratio rose 851.09% to 0.8 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.8, marking a year-over-year increase of 851.09%. This contributed to the annual value of 0.8 for FY2025, which is 851.09% up from last year.
  • According to the latest figures from Q4 2025, Medifast's Equity Ratio is 0.8, which was up 851.09% from 0.8 recorded in Q3 2025.
  • Over the past 5 years, Medifast's Equity Ratio peaked at 0.8 during Q4 2025, and registered a low of 0.38 during Q2 2022.
  • Over the past 5 years, Medifast's median Equity Ratio value was 0.59 (recorded in 2023), while the average stood at 0.62.
  • Per our database at Business Quant, Medifast's Equity Ratio tumbled by 2887.09% in 2022 and then soared by 5313.07% in 2023.
  • Quarter analysis of 5 years shows Medifast's Equity Ratio stood at 0.51 in 2021, then decreased by 3.54% to 0.49 in 2022, then soared by 32.59% to 0.65 in 2023, then rose by 13.71% to 0.74 in 2024, then rose by 8.51% to 0.8 in 2025.
  • Its last three reported values are 0.8 in Q4 2025, 0.8 for Q3 2025, and 0.8 during Q2 2025.